Sales of biogenerics in US, Europe to soar-study LONDON (Reuters)

Sales of biogenerics in US, Europe to soar-study
LONDON (Reuters) - Copycat versions of expensive biotech drugs could see $16.4 billion in sales in the United States and Europe by 2011 once regulatory curbs on so-called biogenerics use are gone, a study showed on Monday.

B vitamins no help in stopping heart attacks-study
STOCKHOLM (Reuters) - Giving B vitamins to heart attack survivors does not cut their risk of having another attack and may actually do more harm than good, researchers said on Monday.

Genes found that may improve knowledge of spina bifida
DUBLIN (Reuters) - Irish scientists said on Monday they have discovered two genes linked to spina bifida that will improve understanding of one of the most common birth defects.

CI Research Has Launched a New Natural Product Aiming Plug the Treatment Gap Left by the Withdrawal From the Market of COX-2 Inhibitors
The withdrawal of major treatments for arthritis and rheumatism due to serious side effects has led to a reduction in available treatment to patients. The drugs; known as COX-2 Inhibitors; have been voluntarily withdrawn by the manufacturers after safety data showed that they were not as safe as fir